Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinomaToshima Z. Parris(Sahlgrenska University Hospital), Khalil Helou(Sahlgrenska University Hospital)International Journal of CancerOctober 12, 201310.1002/ijc.28497Cited by 69SaveCiteExport RISWatch citationsRelated PapersElevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome|BMC Cancer|2013|399Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens|Scientific Reports|2020|220